Quadrant Biosciences CFO, Rich Bongo, answers some of the frequently asked questions we've received about our company and the offering. In this segment, Rich addresses how the equity is structured and our recently received PLA code. 

For more information, including information on the risks involved, please read our offering circular and supplement found here.